Mitchell Ho, PhD

Senior Investigator, Laboratory of Molecular Biology at NIH NCI

Speaker

Dr. Mitchell Ho is Senior Investigator, Deputy Chief of the Laboratory of Molecular Biology, and Director of the Antibody Engineering Program at the National Cancer Institute (NCI), National Institutes of Health. He is internationally recognized for pioneering contributions to antibody engineering and cancer therapeutics, particularly establishing glypicans as therapeutic targets and advancing single-domain antibodies for protein- and cell-based therapies. Dr. Ho is founding Editor-in-Chief of Antibody Therapeutics (Oxford University Press) and an elected Fellow of AIMBE. He was named Asian American Engineer of the Year in 2024. He received his Ph.D. from the University of Illinois at Urbana-Champaign and completed postdoctoral training with Dr. Ira Pastan at NCI.